Multimodality therapy for esophageal cancer

Oncologist

Volumn 1, Issue 4, 1996, Pages 210-218

  Siewert, J R ^a   Stein, H J ^a   Fink, U ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Additive therapy; Adjuvant therapy; Esophageal cancer; Multimodality therapy; Neoadjuvant therapy

Indexed keywords

EID: 0001496148     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.1-4-210     Document Type: Article

References (9)

1. Roder JD, Busch R, Stein HJ et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-413.
2. Hölscher AH, Bollschweiler E, Bumm R et al. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995;118:845-855.
3. Bartels H, Stein HJ, Siewert JR. Surgical therapy of esophageal cancer: preoperative risk analysis and mortality. Br J Surg (in press).
4. Akiyama H, Tsurumaru M, Udagawa H et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:354-373.
5. Hagen JA, Peters JH, DeMeester TR. Superiority of extended en bloc esophagogastrectomy for cancer of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993;106:850-859.
6. Hermanek P, Sobin LH, eds. UICC TNM Classification of Malignant Tumors, 5th revised edition. Berlin: Springer Verlag, 1992.
7. Müller JM, Erasmi H, Stelzner M et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-857.
8. Siewert JR. Ösophagus und Tracheobronchialsystem - Eine schicksalhafte Beziehung. Langenbecks Arch Chir 1990;375:325.
9. Fink U, Stein HJ, Bochtler H et al. Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol 1994;5:S17-S26.